期刊文献+

注射用克拉霉素乳剂稳定性及影响因素考察

Study on the Formulation Stability and Its Influence Factors of Clarithromycin Emulsion for Injection
原文传递
导出
摘要 目的考察克拉霉素乳剂稳定性及其影响因素。方法以乳剂粒径,pH值变化和药物含量作为指标,考察了不同温度对克拉霉素乳剂稳定性的影响。结果乳剂在低温保存时稳定性良好,温度升高会显著影响乳剂稳定性,导致粒径增大和pH降低。根据Arrhenius公式求得储存温度为5℃时,T0.9=9.06年,长期稳定性试验结果表明,载药乳剂在12个月理化性质稳定。结论低温保存有利于提高该乳剂的稳定性。 OBJECTIVE To investigate the formulation stability and influence factor of clarithromycin emulsing. METHODS The particle size, pH reduction and drug content were used as the indexes to investigate the clarithromycin emulsion stability in different storage temperature. RESULTS The drug loaded emulsion was stable when at low storage temperature. As the storage temperature increased, the particle size of clarithromycin emulsion increased significantly. And lead to pH reduction. Based on Arrhenius equation, T0.9 would increase to 9.06 years, when storage temperature was 5 ℃. Long term stability testing results indicate that the physical and chemical properties of clarithromycin emulsion was stable within 12 months. CONCLUSION Low storage temperature is hepful to improve the formulation stability.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2010年第7期630-634,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 克拉霉素 乳剂 稳定性 clarithromycin emulsion stability
  • 相关文献

参考文献6

  • 1PETER D H, CLISSOLD S P. Clafithromycin: A review of its antimierobial activity, pharmaceutic properties and therapeutic potential [J]. Drugs, 1992, 44(1): 117-164.
  • 2LANGTRY H D, BROGDEN R N. Clarithromycin: A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients [J]. Drugs, 1997, 53(6): 973-1004.
  • 3ANDERSON R, JOONE G, RENSBURG C E. An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin, a new macrolide antimicrobial agent [J]. J Antimicrob Chemother, 1988, 22(6): 923-933.
  • 4CELLS G, GEA E, ROIG J, et al. Comparative tolerability of intravenous erythromycin and clarithromycin in hospitalised patients with community-acquired pneumonia results of a double-blind, randomised, prospective study [J]. Clin Drug Invest, 2002, 22(6): 393-398.
  • 5ZIMMERMANN T, LAUFEN H, RIEDEL K D, et al. Comparative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers results of a double-nlind, double-dummy, four-way crossover study [J]. Clin Drug Invest, 2001, 21(8): 527-536.
  • 6秦凌浩,唐星.注射用克拉霉素乳剂的制备及其体内外评价[J].药学学报,2006,41(10):945-949. 被引量:6

二级参考文献17

  • 1Peter DH,Clissold SP.Clarithromycin:a review of its antimicrobial activity,pharmaceutical properties and therapeutic potential[J].Drugs,1992,44:117-164.
  • 2Langtry HD,Brogden RN.Clarithronycin:a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients[J].Drugs,1997,53:973 -1004.
  • 3Anderson R,Joone G,Rensburg EJ.An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin,a new macrolide antimicrobial agent[J].J Antimicrob Chemother,1988,22:923-933.
  • 4Celis G,Gea E,Roig J.Comparative tolerability of intravenous erythromycin and clarithromycin in hospitalised patients with community-acquired pneumonia results of a double-blind,randomised,prospective study[J].Clin Drug Invest,2002,22:393-398.
  • 5Torsten Z,Heinrich L,Klaus DR,et al.Comparative tolerability of intravenous azithromycin,clarithromycin and erythromycin in healthy volunteers results of a doubleblind,double-dummy,four-way crossover study[J].Clin Drug Invest,2001,21:527 -536.
  • 6Lovell MW,Johnson HW,Hui HW.Less-painful emulsion formulations for intravenous administration of clarithromycin[J].Int J Pharm,1994,109:45-57.
  • 7Caillot D,Casasnovas O,Solary E,et al.Efficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients[J].J Antimicrob Chemother,1993,31:161-169.
  • 8Menashe YL,Lev L,Shoshanna GS,et al.Side-effect evaluation of a new diazepam formulation:venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits[J].Pharm Res,1989,6:510 -516.
  • 9Eugene HC,Catherijen AK,Victorine SK,et al.Influence of different fat emulsion based intravenous formulation on the pharmacokinetics and pharmacodynamics of propfol[J].Pharm Res,1998,15:442 -448.
  • 10Toichi T,Kiyoshi K,Yoshinobu T,et al.Long circulating emulsion carrier systems for highly lipophilic drugs[J].Biol Pharm Bull,1994,17:121 -125.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部